Discussing PsA: Uveitis risk and treatment sequencing outcomes in axSpa and PsA
The IMID Forum
- Published
- December 4, 2025
- Duration
- 20:47
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of P…
Summary
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secukinumab and adalimumab’ and ‘the efficacy of long-term treatment with risankizumab across the updated GRAPPA domains and key related conditions of PsA’.
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Professor Laura Coates and Phillip Mease as they discuss the top publications in the world of PsA. This month, the conversation covered the ‘the effectiveness and safety of upadacitinib with secukinumab and adalimumab’ and ‘the efficacy of long-term treatment with risankizumab across the updated GRAPPA domains and key related conditions of PsA’.